Market intelligence - Page 2

Stay up to date with the latest Market intelligence updates from the global world pharmaceuticals industry

Positive reaction: public opinion of adjuvants 05 July, 2013 Since the emergence of vaccines, eliciting a strong immune response among...

Riding pharma’s R&D rollercoaster 27 March, 2013 Following a period of decline in delivery, and in anticipation of...

Shaping the future of clinical data management 06 March, 2013 Data is the bedrock of any clinical trial, so changes to the processes...

Coming together in hard times: biotech funding 22 February, 2013 The productivity of the biotech industry is still in question and...

Top ten generic companies 21 September, 2012 GlobalData highlights the top ten generic pharmaceutical companies by...

Identity trust in cyberspace 21 September, 2012 As the industry embraces mobile computing, Mollie Shields-Uehling,...

Take five: significant pharma industry deals in Q2/Q3 21 September, 2012 With insight from GlobalData, we take a look at five of the recent deals...

Pharma deals on the rise 02 March, 2012 The quantity of mergers and acquisitions is falling in the pharmaceutical...

Top ten generic pharma 02 March, 2012 The impending patent cliff will mean losses for Big Pharma, but gains...

Features By Category view all



Privacy Policy
We have updated our privacy policy. In the latest update it explains what cookies are and how we use them on our site. To learn more about cookies and their benefits, please view our privacy policy. Please be aware that parts of this site will not function correctly if you disable cookies. By continuing to use this site, you consent to our use of cookies in accordance with our privacy policy unless you have disabled them.